Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease

Nat Immunol. 2006 Nov;7(11):1151-6. doi: 10.1038/ni1391. Epub 2006 Sep 24.

Abstract

It is unclear whether TGF-beta, a critical differentiation factor for T cells producing interleukin 17 (T(H)-17 cells), is required for the initiation of experimental autoimmune encephalomyelitis (EAE) in vivo. Here we show that mice whose T cells cannot respond to TGF-beta signaling lack T(H)-17 cells and do not develop EAE despite the presence of T helper cell type 1 infiltrates in the spinal cord. Local but not systemic antibody blockade of TGF-beta prevented T(H)-17 cell differentiation and the onset of EAE. The pathogen stimulus zymosan, like mycobacterium, induced T(H)-17 cells and initiated EAE, but the disease was transient and correlated with reduced production of interleukin 23. These data show that TGF-beta is essential for the initiation of EAE and suggest that disease progression may require ongoing chronic inflammation and production of interleukin 23.

MeSH terms

  • Animals
  • Cell Differentiation / immunology
  • Chronic Disease
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / metabolism
  • Encephalomyelitis, Autoimmune, Experimental / pathology*
  • Immune Sera / administration & dosage
  • Inflammation / immunology
  • Interleukin-23 / biosynthesis
  • Interleukin-23 / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Signal Transduction / immunology*
  • T-Lymphocytes, Helper-Inducer / immunology
  • T-Lymphocytes, Helper-Inducer / pathology
  • Transforming Growth Factor beta / immunology
  • Transforming Growth Factor beta / physiology*

Substances

  • Immune Sera
  • Interleukin-23
  • Transforming Growth Factor beta